Did someone steal your aluminium hat?
One prostitute doesn’t get her shot and it goes through the whole team…
Misunderstood it, got a letter today that ‘they’ already made an appointment for me. Next Monday it is my turn to get the AstraZeneca stuff. 
@Scott.Jones, sorry mate this is not the same product you normally use. 
2 Likes
https://valneva.com/press-release/valneva-reports-positive-phase-1-2-data-for-its-inactivated-adjuvanted-covid-19-vaccine-candidate-vla2001/?lang=fr
Health and Social Care Secretary, Matt Hancock said: “The U.K. government has funded these clinical trials and it is fantastic to see Valneva’s vaccine produces a strong immune response. This vaccine will be made onshore in Livingston in Scotland, giving another boost to British life science, and if approved will play an important role in protecting our communities. I look forward to seeing the results of the upcoming phase 3 trial.”
Vaccines Minister Nadhim Zahawi said**: “** These results are very promising and provide renewed hope that a vaccine using a whole inactivated virus might provide strong protection against variants. If the results from the phase 3 clinical trials are positive and the vaccine meets the robust standards of safety, quality and effectiveness of our medicines regulator, the MHRA, this will be another powerful weapon in our arsenal to beat this pandemic. The government has funded the clinical trials for this promising vaccine and, if approved, it will be manufactured in Scotland, boosting the UK’s ability to become more self-sufficient in the future.”
Clive Dix, Chair of the Vaccines Taskforce said: “These are great results from Valneva, particularly around the antibody and cellular responses generated and low numbers of adverse events, as these indicate good levels of immune responses among the participants to date. The findings of 100% levels of immunogenicity against the viral spike protein in the high-dose group is also encouraging. Inactivated virus vaccines are proven technologies that are often able to induce wide-ranging immune responses, and these promising data indicate that VLA2001 may continue this trend. We are hopeful of seeing good results from the upcoming Phase 3 trials, and look forward to continuing working closely with Valneva on their vaccine.”
I don’t like that headline, sounds ridiculous imo, but it’s slowly starting to look much better now. Fingers crossed.
1 Like
Time for the EU to start giving its doses to the rest of the world who are not as advanced at it is with their roll outs, you know, in the interests of fairness? As opposed to blocking the lawful exports of life-saving vaccines from private companies that happen to be based within its territory.
The debate has shifted over the last few weeks from unless you deliver all the vaccines we will sue you. Blood is on your hands. To so what, if European countries don’t use the vaccine on a large proportion of the population, we have other vaccines, the virus risk is not so bad in countries like Norway.
I have had a constant message the European countries have reacted as if there was not a pandemic. The wrong measures of risk and reward. The wrong messaging to the public.
@JU97ICE this is where we differ fundamentally.
Those in the EU/European nations have long justified that their safety first approach is what inspires confidence. The reality is it has done the complete opposite. Recent poll shows 23% of people in France feel AZ vaccine is safe. 31% in Germany. That’s a tragedy. General vaccinate skepticism among the highest in the world.
That’s the effect of suspending for over 65s. Suspending for every age group, and then suspending for under 65s. It’s also a result of criticism of UK for rushing through approval, not being as safe as the EU. Also the press about the risky delays between two doses.
That’s a failure of government. That even today 2.1 M AZ doses are unused in France (basically half of what has been delivered). Over a million in Germany. It’s clear as day what’s going to occur. Vaccine hesitancy means that quietly the AZ doses will be donated to poorer countries as a gesture. Within the EU first and then later to Africa.
The best measure of risk/reward is looking at the death rate in the UK with half its population vaccinated vs European countries entering its third wave lockdown.
Today the EU blocked 3M does of AZ vaccine to Australia. I don’t see that as European countries wanting the AZ vaccine. I simply see that as a disconnected strategy.
2 Likes
Add Japan to the list of countries producing the AstraZeneca vaccine.
Apparently it’s ready to be rolled out.
In the meantime Japan had to turn to supplies from the US due to the EU’s unlawful/immoral imposition of export controls.
Not great.
Better late than never but facilities in France are finally set to start producing coronavirus vaccines (on behalf of Moderna and Pfizer mostly).
I’ve seen some references to polysorbate 80 being included in the AstraZeneca and J&J vaccine with some links to blood clots. Pfizer and Moderna contain PEG (which I think polysorbate 80 is a class of but do not include polysorbate 80 itself).
Ironically, it seems, PEG in Pfizer may cause an allergic response (which is why AstraZeneca is being recommended in preference for those with allergies) but polysorbate 80 may be a causal link to clotting (even if the instances remain rare).
Have the toilet roll ready!!
1 Like
This has been brewing for some time. I listened to a radio phone in on this a couple / three weeks ago and to be honest your link could be equally posted in the Racism thread.
Apparently, these ethnic minority groups are skeptical in no large part due to the racism that we apparently dont have in this country. These people simply do not trust what the government and other such official bodies tell them, about anything, not only vaccines.
More AZ shaming - https://www.npr.org/2021/04/04/984274691/johnson-johnson-to-oversee-vaccine-production-at-baltimore-facility
After a mix up at a contract manufacturing plant in Baltimore that was producing both AZ and the new J&J shot, the FDA has directed that the plant should be used now to produce only the J&J shot, and is to be operated by J&J themselves.
From a purely UScentric perspective this makes sense, as it shifts manufacturing towards the version that is approved here. I have no idea how important this plant was though to global AZ supplies and so there is potential for there to be a further hit to AZ rep if this makes it even more difficult to supply their buyers in other countries.
Absolutely, but the way it’s been reported suggests, incorrectly, that AstraZeneca have been kicked out because they were responsible for the fuck up.
The Netherlands yesterday; 89.734 jabs best so far for one day.
3 Likes
Add Australia to the list of countries producing the AstraZeneca vaccine.
So that’s the UK, Belgium, Netherlands, USA, Argentina, India, Japan and Australia that I’ve been able to identify (there are apparently 15 in total).
This is effectively what the UK exported (the licence to produce the vaccine in regional hubs at cost) allowing the production facilities funded by the UK (two in the UK and one in the EU) to produce vaccines for the UK.
Oh, South Korea as well, SK Bioscience
That’s 9 different countries so far.
This is what AstraZeneca say:
01
Introduction
AstraZeneca takes responsibility for the safety, effectiveness and quality of all the COVID-19 vaccine made in our global supply network of manufacturing facilities across Europe, North, Central and South America, Asia and Australia. This means that every batch made in our supply network must meet the same exacting production and quality standards.
At every stage of the production process there is a continuous demand to test, record, analyse, report, confirm and verify.
In a traditional drug supply chain, finished product may be stored for weeks or months until it is needed to meet public health requirements. However, in the current pandemic, it’s essential that every dose is available for administration as quickly as possible. This means that a batch of COVID-19 vaccine can be shipped to national/regional distribution hubs within hours of the final release certificate being received from a government regulator.
AstraZeneca’s many years of experience manufacturing our live virus influenza vaccine meant that our COVID-19 vaccine operation was built on solid foundations and strong expertise. However, supplying a vaccine to combat an infection that threatens the entire world of nearly 8 billion people, has put unprecedented demand on all raw materials, limited manufacturing capacity and posed incredible operating constraints.
COVID-19-related travel restrictions on people and supplies, and workforce illness and need for self-isolation, have presented additional unique challenges.
Only through comprehensive planning, creative thinking, rapid problem solving, continuous collaboration with all our partners, and 24/7 commitment, have we been able to contribute to the global effort to overcome the COVID-19 pandemic.
When you set up production for a vaccine or medicine, the most important thing is to ensure you have rock solid control over all the production processes, with rigorous procedures in place to ensure the product is made to the correct standards of safety, efficacy and quality. Subsequent testing of your product should be confirmatory, it’s how you set up your processes at the beginning that’s key.
Dave ClarkVP Technical Operations
02
Addressing the challenge of global vaccine demand
To help meet global demand for COVID-19 vaccine, AstraZeneca rapidly conducted due diligence with more than 60 potential partners to ultimately build a global supply network of more than 25 proven manufacturing organisations in 15 countries with the capability and capacity to supply the vaccine. With each partner, the technology transfer process began immediately to ensure that not a minute was wasted in our quest to rapidly establish commercial manufacturing ahead of regulatory approval/authorisation. During this process, our technical experts worked around the clock with our supply partners to transfer our validated protocols and standard methods for vaccine production. As our teams were unable to travel due to the pandemic, we used virtual technology to provide real-time technical support and coaching to production teams on each site.
It’s really frustrating how these issues keep being reported. This is just from today.
It starts, clots definitely linked to AstraZeneca vaccine…
Then an update an hour or so later, actually still not sure of the cause of clots…
Then a few hours later it’s further qualified, EMA has still not reached a conclusion on AstraZeneca/Blood clot link and the review remains ongoing.
Meanwhile public confidence… 
I couldn’t find any report that suggested that.